We also showed that DNMT1 inhibition eliminates the Akt-YAP1-CCA region while leaving the HCC region intact, indicating that DNMT1 is required for AKT-YAP-mediated HC-to-CCA reprogramming but is dispensable for HC transformation into HCC. The gene discussed is YAP1; the disease is hepatocellular carcinoma.